Pacer Advisors, Inc. Vir Biotechnology, Inc. Transaction History

Pacer Advisors, Inc.

$38.6 Billion
Q1 2024

A detailed history of Pacer Advisors, Inc. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 2,203 shares of VIR stock, worth $18,791. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,203

Previous 159 1285.53%

Holding current value

$18,791

Previous $1,000 2100.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$8.6 - $11.9 $17,578 - $24,323	2,044 Added 1285.53%	2,203 $22,000
Q4 2023 Jan 16, 2024	SELL	$7.76 - $10.29 $302 - $401	-39 Reduced 19.7%	159 $1,000
Q2 2023 Jul 12, 2023	BUY	$23.2 - $27.29 $649 - $764	28 Added 16.47%	198 $4,000
Q1 2023 May 02, 2023	SELL	$22.26 - $30.85 $24.5 Million - $33.9 Million	-1,099,224 Reduced 99.98%	170 $3,000
Q4 2022 Feb 06, 2023	BUY	$19.96 - $28.22 $21.9 Million - $31 Million	1,099,190 Added 538818.62%	1,099,394 $27.8 Million

Q3 2022 Oct 18, 2022	SELL	$18.26 - $31.1 $14.3 Million - $24.4 Million	-784,207 Reduced 99.97%	204 $4,000
Q2 2022 Aug 12, 2022	BUY	$19.08 - $26.7 $15 Million - $20.9 Million	784,139 Added 288286.41%	784,411 $20 Million
Q1 2022 Apr 05, 2022	SELL	$21.19 - $40.01 $1,419 - $2,680	-67 Reduced 19.76%	272 $7,000
Q4 2021 Feb 03, 2022	BUY	$30.97 - $54.03 $4,862 - $8,482	157 Added 86.26%	339 $14,000
Q2 2021 Jul 21, 2021	SELL	$38.75 - $51.0 $60,333 - $79,407	-1,557 Reduced 89.53%	182 $9,000
Q1 2021 Apr 05, 2021	SELL	$26.34 - $83.07 $69,511 - $219,221	-2,639 Reduced 60.28%	1,739 $89,000
Q4 2020 Jan 20, 2021	BUY	$25.51 - $43.38 $107,295 - $182,456	4,206 Added 2445.35%	4,378 $117,000
Q3 2020 Oct 19, 2020	BUY	$28.28 - $53.6 $2,432 - $4,609	86 Added 100.0%	172 $6,000
Q2 2020 Jul 29, 2020	BUY	$27.89 - $47.86 $2,398 - $4,115	86 New	86 $4,000

Others Institutions Holding VIR

# of Institutions

225

Shares Held

88.2M

Call Options Held

177K

Put Options Held

182K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.13B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Vir Biotechnology, Inc. Transaction History